Antigen-affinitätsgereinigte Polyklonale Antikörper

Anti-Human GRO-α/MGSA (CXCL1)

0 ReviewsSubmit a Review

Product Details

Catalogue Number: 500-P92
Description:
Anti-Human GRO-α/MGSA (CXCL1)
 

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human GRO-alpha/MGSA (CXCL1). Anti-Human GRO-alpha/MGSA (CXCL1)-specific antibody was purified by affinity chromatography employing immobilized Human GRO-alpha/MGSA (CXCL1) matrix.

Immunogen: E.coli derived Recombinant Human GRO-α/MGSA (CXCL1) (PeproTech catalog# 300-11)

Sandwich ELISA: To detect Human GRO-α/MGSA by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human GRO-α/MGSA (500-P92Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human GRO-α/MGSA.

Anti-Human GRO-α/MGSA (CXCL1) Sandwich ELISA

Western Blot: To detect Human GRO-α/MGSA by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. When used in conjunction with compatible secondary reagents, the detection limit for recombinant Human GRO-α/MGSA is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Human GRO-α/MGSA (CXCL1) Western Blot Reduced Anti-Human GRO-α/MGSA (CXCL1) Western Blot Unreduced

Note:

Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

crossreactivity:
Country Of Origin: USA

Not for human use.

Research Interest

product.subtitle.recentcitations

First Author
Bouhaddou, M
Title
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
Citation
Cell; 182(3) pg685-712.e19
PubMed Id
First Author
Cheng, W
Title
Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression.
Citation
PLoS ONE; 7(3) pge34352
PubMed Id
First Author
Hol, J
Title
Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies.
Citation
PLoS ONE; 7(7) pge40673
PubMed Id